25 / 60
25
Scientific programme
Friday, 29 May 2015
P-08-010 The use of mindfulness mediation and
emotion regulation for children with
ADHD
N. Leventhal, Canada
D. Almagor, D. Almagor
P-09
Guided Poster Tour
16:00–17:30
Hall 2 – Poster Area
Non-pharmacological treatment – children and
adolescents II
Chair:
M. Solanto, USA
P-09-001 Assessing the effectiveness of the
‘Incredible Years(
®
) parent training‘ to
parents of schoolage children with ADHD
A. Kerridge, Canada
K. Dawson, S. Schmiedel, M.-P. Vandette,
P. Robaey
P-09-002 Effects of brain-computer interface-based
attention training programme for ADHD
X. Lee, Singapore
D. S. Sheng Fung, R. Phillips, C. Guan, T.-S.
Lee, C. G. Lim
P-09-003 Emotion control in children with ADHD,
examination of self-report, observational,
and physiological components
S. Li-Yu, Taiwan
P-09-004 Implementation evaluation of a social
skills training programme for children
with ADHD in school, community and
child psychiatry clinic settings
L. Massé, Canada
C. Verret
P-09-005 The WHAAM application: An evidence-
based application to support behavioural
interventions
G. Merlo, Italy
C. Giuseppe, M. Sanches-Ferreira, C. McGee,
G. Doherty, D. Spachos
P-09-006 The role of group parent education on
medication adherence in children with
Attention-Deficit/Hyperactivity Disorder
H. Gao, People‘s Republic of China
D. Zhu
P-09-007 Tomatis method as a therapy for children
and adults which can improve the quality
of life of ADHD people
S. Kashirina, Russia
Y. Golubeva
P-09-008 Addressing disparities between Latinos and
non-Latinos accessing a school-home col-
laborative behavioral treatment for ADHD
L. Haack, USA
E. A. Araujo, M. Capriotti, A. Beaulieu,
K. McBurnett, L. Pfiffner
P-09-009 Listening therapy as a non-pharmacolo
gical treatment, which can reduce ADHD
symptoms in children
S. Kashirina, Russia
Y. Golubeva
P-10
Guided Poster Tour
16:00–17:30
Hall 2 – Poster Area
Pharmacological treatment – children and
adolescents I
Chair:
G. Kohls, Germany
P-10-001 Population pharmacokinetics models to
guide prescription combining immediate
and modified-release methylphenidate
G. Bonnefois, Canada
P. Robaey, O. Barrière, J. Li, F. Nekka
P-10-002 ADHD stimulant response. Clinical predic-
tion research
L. Duño-Ambros, Spain
E. Pujals-Altés, X. Estrada-Prat, M. T.
Nascimento-Osorio, A. Petrizan-Aleman, S.
Batlle Vila, E. Baeza-Tena, E. Camprodon
Rosanas, V. Perez-Sola, L. M. Martin-Lopez
P-10-003 Behavioural investigation of the effect of
methylphenidate among children with
ADHD in Taiwan: A preliminary study
S.-J. Hung, Germany
C.-M. Yu, M.-H. Hsieh, C. Gawrilow, S.
S.-Fen Gau
P-10-004 Nationwide data for short- and long-term
medication compliance of ADHD in Korea
M. Hong, Republic of Korea
J. Han, G. H. Bahn, B. Kim, J.-W. Hwang, H.-y.
Choi, I. H. Oh, Y. J. Lee
P-10-005 Clinical efficacy of guanfacine extended
release among children with primarily
inattentive subtype of Attention-Deficit/
Hyperactivity Disorder: Results from
3 studies in four phases
M. Huss, Germany
K. McBurnett, A. Cutler, A. Hervas, B. Adeyi,
B. Dirks